RSV study seeks immune clues in older adults
NCT ID NCT06274619
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how the immune system of healthy adults aged 65-75 responds to RSV, a common cause of chest infections. Researchers gave volunteers a mild RSV infection and took blood and nose samples to find immune markers linked to protection. The goal is to use these findings to develop better vaccines, tests, and treatments for older adults at higher risk.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESPIRATORY SYNCYTIAL VIRUS INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Imperial Clinical Research Facility, Imperial College Healthcare NHS Trust
London, W12 0HS, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A gentle touch against coughs and colds: could manual therapy shorten respiratory illness?
- Can a simple breath test catch flu in High-HIV regions?
- New AI-Powered swab test aims to spot viruses in minutes
- AI stethoscope aims to cut unnecessary antibiotics in kids with cough
- RSV drug trial for kids under 5 halted early – only 4 children enrolled
- Placenta cells tested as COVID fighter – but trial stopped early